全球合約銷售組織 (CSO) 市場：按服務類型、治療領域、最終用戶和地區分類

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type, By Therapeutic Area, By End User, By Geography

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球醫藥合約銷售組織（CSO）市場預計到2026年將達到116.945億美元，預計到2033年將達到213.78億美元。預計從2026年到2033年，該市場將以9.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	116.945億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.00%	2033年市場規模預測：	213.78億美元

近年來，全球醫藥合約銷售組織 (CSO) 市場呈現令人矚目的成長動能。製藥公司擴大將銷售和行銷業務外包給專業的 CSO 服務商，以便專注於藥物研發。 CSO 公司協助製藥公司最佳化銷售營運、管理銷售負責人拜訪，並確保促銷活動符合監管準則。他們還利用數據驅動的見解和技術解決方案來提高銷售負責人的效率並擴大醫生覆蓋範圍。這種外包模式使製藥公司能夠在不承擔高額固定成本的情況下，利用專業知識並提高營運效率。這種經濟高效的方式正受到尋求簡化商業化流程的生物製藥企業的青睞。

市場動態：

全球醫藥合約行銷外包 (CSO) 市場的發展受到多種因素的驅動，例如生物製藥公司需要最佳化銷售成本並提高生產效率。日益複雜的醫藥促銷法規，尤其是在美國，也促使製藥公司將銷售業務外包給在合規框架方面擁有專業知識的專業 CSO 服務商。此外，客戶關係管理 (CRM) 和數據分析技術的進步也推動了銷售外包需求的成長。然而，醫藥定價環境的波動以及某些地區不利的醫療體系改革給市場參與者帶來了挑戰。 CSO 產業的重組也對客戶關係產生了影響。新的機會包括進軍非常規治療領域以及提供與市場進入相關的附加價值服務。

企業日益成長的精簡和提升銷售流程效率的需求，將進一步推動對銷售計劃和績效分析軟體的需求。例如，2025年11月7日，數位科技公司Accenture)和軟體公司銷售團隊宣佈建立合作夥伴關係，共同打造面向生命科學公司的人工智慧(AI)雲端服務。根據這項合作協議，Accenture將把其在生物醫學研究行業和人工智慧技術領域的專業知識整合到「Salesforce生命科學雲」中，以幫助實現該軟體提升醫療技術、生物技術和製藥公司效率的目標。

本研究的主要特點：

這項研究揭示了各個細分市場的潛在成長機會，並為該市場說明了一個有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數，對全球醫藥合約行銷外包 (CSO) 市場中的主要公司進行了概況介紹：公司概況、產品系列、主要亮點、財務績效和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「全球藥品寄售組織 (CSO) 市場」報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業利益相關相關人員。
相關人員可以透過分析全球醫藥合約行銷外包 (CSO) 市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- IQVIA Inc.
- Syneos Health Inc.
- Parexel International Corporation
- PPD
- ICON plc
- Publicis Touchpoint Solutions, Inc.
- PRA Health Sciences, Inc.
- The Medical Affairs Company（TMAC）
- Ashfield Healthcare Communications Group
- GTS Solutions
分析師意見

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI6549

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market is estimated to be valued at USD 11,694.5 Mn in 2026 and is expected to reach USD 21,378.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 11,694.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.00%	2033 Value Projection:	USD 21,378.0 Mn

The global pharmaceutical contract sales outsourcing (CSO) market has shown promising growth in recent years. Pharmaceutical manufacturers are increasingly outsourcing their sales and marketing operations to specialized CSO providers in order to focus on drug research and development. CSO firms assist drug makers in optimizing sales operations, managing representative visits, and ensuring promotional compliance with regulatory guidelines. They leverage data-driven insights and technological solutions to enhance sales representative effectiveness and expand physician reach. The outsourcing model enables pharmaceutical companies to access specialized expertise and achieve operational efficiencies without incurring high fixed costs. This cost-effective approach has thus gained traction among biopharma firms looking to streamline commercialization activities.

Market Dynamics:

The global pharmaceutical contract sales outsourcing (CSO) market is driven by factors such as the need of biopharma players to optimize sales costs and boost productivity. Growing complexity of drug promotion regulations particularly in the U.S. also prompts pharmaceutical companies to outsource sales operations to specialized CSO providers well-versed with compliance frameworks. Additionally, technological advancements in customer relationship management and data analytics are translating into increased demand for outsourced sales capabilities. However, volatility in drug pricing environments and unfavorable healthcare reforms in certain regions pose challenges to market players. Furthermore, consolidation in the CSO industry landscape impacts client relationships. Emerging opportunities lie in expansion into non-traditional therapeutic areas and offering value-added services around market access.

Increasing requirement for companies to streamline the sales process and achieve higher efficiency will further aid in the demand for sales planning/performance analytics software. For instance, on November 7, 2025, Accenture, a digital technology company, and Salesforce, Inc., a software company, announced the collaboration to build an Artificial intelligence (AI) powered cloud service for life sciences companies. Under the collaborations, Accenture added its own expertise both in the biomedical research industry and in artificial intelligence technologies to the Salesforce Life Sciences Cloud to help fulfill the new software's mission of making medtech, biotech, and pharma companies more efficient.

Key Features of the Study:

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharmaceutical contract sales outsourcing (CSO) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IQVIA Inc., Syneos Health Inc., Parexel International Corporation, PPD, ICON plc, Publicis Touchpoint Solutions, Inc., PRA Health Sciences, Inc., The Medical Affairs Company (TMAC), Ashfield Healthcare Communications Group, and GTS Solutions
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pharmaceutical contract sales outsourcing (CSO) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical contract sales outsourcing (CSO) market

Detailed Segmentation:

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type (Revenue, USD Mn, 2021 - 2033)
Personal Promotion
Non-personal Promotion
Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Therapeutic Area (Revenue, USD Mn, 2021 - 2033)
Cardiovascular Disorders
Oncology
Metabolic Disorders
Neurology
Orthopedic Diseases
Infectious Diseases
Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By End User (Revenue, USD Mn, 2021 - 2033)
Biopharmaceutical Companies
Medical Device Companies
Generic Companies
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in the Global Pharmaceutical Contract Sales Outsourcing (CSO) Market:
IQVIA Inc.
Syneos Health Inc.
Parexel International Corporation
PPD
ICON plc
Publicis Touchpoint Solutions, Inc.
PRA Health Sciences, Inc.
The Medical Affairs Company (TMAC)
Ashfield Healthcare Communications Group
GTS Solutions

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Service Type
- Market Snippet, By Therapeutic Area
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Digital technology adoption
- Access to care disparities
- Population health initiatives
Key Highlights
Regulatory Scenario
Recent Trends
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Personal Promotion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Non-personal Promotion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Therapeutic Area, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Orthopedic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By End User, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Generic Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

7. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Region, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 - 2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profile
- IQVIA Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Syneos Health Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Parexel International Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- PPD
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- ICON plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Publicis Touchpoint Solutions, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
  - Strategies
- PRA Health Sciences, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- The Medical Affairs Company (TMAC)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Ashfield Healthcare Communications Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GTS Solutions
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views